Conjoint Associate Professor Peter Schofield

Conjoint Associate Professor

School of Medicine and Public Health

Career Summary

Biography

I trained in Neurology and Geriatrics in Australia (FRACP) and Behavioural Neurology and Epidemiology in the USA at Columbia Presbyterian Medical Centre and Columbia University in New York City. My research in the USA was concerned with epidemiological aspects of dementing disorders. After returning to Australia in 1997, I was appointed as Clinical Director to establish and develop a neuropsychiatry service which now serves the greater Newcastle area and northern NSW. My research in Australia has focused on efforts to develop simple and cost effective means of detecting cognitive impairment leading to the creation of the Audio Recorded Cognitive Screen. More recently, we have been exploring novel ways to assess olfaction as a possible biomarker for early Alzheimer's disease. My other main area of research relates to neuropsychiatric issues in offender populations, particularly traumatic brain injury and impulsivity.   

Research Expertise
I have undertaken epidemiological studies of aging and dementia, traumatic brain injury, and solvent exposure. I have developed a novel cognitive assessment instrument with wide potential.

Teaching Expertise
I have taught at undergraduate, postgraduate and at 'masterclass' level' in my areas of expertise

Administrative Expertise
I am director of the Neuropsychiatry Service of Hunter New England Health which comprises over 30 individuals.

Collaborations
I collaborate with Prof John Attia in longitudinal studies of aging (Hunter Community Study) and an NHMRC funded study to investigate the properties of a novel olfactory test paradigm. I collaborate with Professor Tony Butler of the Kirby Institute in Sydney in relation to studies concerned with offender populations. Other collaborations relate to the application of our cognitive test instrument, including particularly in the context of multiple sclerosis with A/Prof Jeannette Lechner-Scott.


Qualifications

  • Doctor of Medicine, Monash University
  • Bachelor of Science (Honours), Monash University
  • Bachelor of Medicine, Bachelor of Surgery, Monash University
  • Master of Science (Epidemiology), Columbia University - New York - USA

Keywords

  • Cognition
  • Dementia
  • Epidemiology
  • Neurology
  • Neuropsychiatry
  • Traumatic brain injury

Fields of Research

CodeDescriptionPercentage
110308Geriatrics and Gerontology30
110999Neurosciences not elsewhere classified40
111706Epidemiology30

Professional Experience

Academic appointment

DatesTitleOrganisation / Department
1/01/1998 - Clinical Director of Neuropsychiatry ServiceHunter New England Health
School of Medicine and Public Health
Australia

Membership

DatesTitleOrganisation / Department
Member - Pfizer / Neuroscience Research Grant Selection Committee Pfizer / Neuroscience Research Grant Selection Committee
Australia
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (11 outputs)

YearCitationAltmetricsLink
2013Schofield PW, Lechner-Scott J, Loughland C, Moore T, 'The Audio Recorded Cognitive Screen (ARCS): a flexible and versatile instrument for clinic or research', Screening tests: principles, analysis and benefits, Nova Science publishers, Hauppauge, NY .-. (2013)
2013Schofield PW, Moore T, Loughland C, Lechner-Scott J, 'The Audio Recorded Cognitive Screen (ARCS): A flexible and versatile instrument for clinic or research', Screening Tests, Nova Science, Hauppaugue, NY 111-126 (2013) [B1]
Co-authorsCarmel Loughland
2006Schofield PW, 'Discrepancies in cognitive history from patient and informants in relation to cognitive function', Research and Practice in Alzheimer's Disease, ., . 328-331 (2006)
2006Schofield PW, 'Discrepancies in cognitive history from patient and informants in relation to cognitive function', Research and Practice in Alzheimer's Disease, Serdi Publisher, Paris 328-331 (2006) [B1]
2003Schofield PW, 'The Ageing Brain', The Ageing Brain, Swets & Zeitlinger, Lisse, The Netherlands (2003)
2003Schofield PW, 'The brain reserve hypothesis', The ageing brain, Swets & Zeitlinger Publishers, Lisse ; Exton (PA) 223-241 (2003) [B2]
1998Schofield PW, Mayeux RM, 'Alzheimer's disease: Clinical features, Diagnosis and Epidemiology', Neuropathology of Dementing Disorders, Edward Arnold, London .-. (1998)
1997Schofield PW, Jacobs DM, 'Biological and psychosocial risk factors for dementia and memory loss', Memory in neurodegenerative disease: biological, cognitive and clinical perspectives, Cambridge University Press, New York N.Y. .-. (1997)
1997Schofield PW, Mayeux RM, 'Clinical aspects of Alzheimer's disease', Principles and Practice of Geriatric Medicine, third edition, John Wiley & Sons, Sussex UK .-. (1997)
1996Schofield PW, Maestre G, Chun M, Tang M-X, Tycho B, Mayeux R, 'Ethnic Variation in the Association between APOE-e4 and Alzheimer's Disease', Apolipoprotein E and Alzheimer¿s Disease, Springer, . 70-79 (1996)
1994Schofield PW, Mayeux R, 'Alzheimer's disease', Principles of Geriatric Medicine and Gerontology, McGraw-Hill Inc, New York, NY 1035-1050 (1994)
Show 8 more chapters

Journal article (66 outputs)

YearCitationAltmetricsLink
2015Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M, et al., 'Plasma Protein Profiling of Mild Cognitive Impairment and Alzheimer's Disease Across Two Independent Cohorts', JOURNAL OF ALZHEIMERS DISEASE, 43 1355-1373 (2015)
DOI10.3233/JAD-141266Author URL
CitationsScopus - 1
Co-authorsJohn Attia
2015Davies G, Armstrong N, Bis JC, Bressler J, Chouraki V, Giddaluru S, et al., 'Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).', Mol Psychiatry, 20 183-192 (2015)
DOI10.1038/mp.2014.188Author URL
CitationsWeb of Science - 1
Co-authorsLiz Holliday, Rodney Scott, John Attia, Christopher Oldmeadow
2015Gardner A, Iverson GL, Levi CR, Schofield PW, Kay-Lambkin F, Kohler RMN, Stanwell P, 'A systematic review of concussion in rugby league', British Journal of Sports Medicine, 49 495-498 (2015)

Objectives: Concussion remains one of the inherent risks of participation in rugby league. While other injuries incurred by rugby league players have been well studied, less focus and attention has been directed towards concussion. Review method: The current review examined all articles published in English from 1900 up to June 2013 pertaining to concussion in rugby league players. Data sources: Publications were retrieved via six databases using the key search terms: rugby league, league, football; in combination with injury terms: athletic injuries, concussion, sports concussion, sports-related concussion, brain concussion, brain injury, brain injuries, mild traumatic brain injury, mTBI, traumatic brain injury, TBI, craniocerebral trauma, head injury and brain damage. Observational, cohort, correlational, cross-sectional and longitudinal studies were all included. Results: 199 rugby league injury publications were identified. 39 (20%) were related in some way to concussion. Of the 39 identified articles, 6 (15%) had the main aim of evaluating concussion, while the other 33 reported on concussion incidence as part of overall injury data analyses. Rugby league concussion incidence rates vary widely from 0.0 to 40.0/1000 playing hours, depending on the definition of injury (time loss vs no time loss). The incidence rates vary across match play versus training session, seasons (winter vs summer) and playing position (forwards vs backs). The ball carrier has been found to be at greater risk for injury than tacklers. Concussion accounts for 29% of all injuries associated with illegal play, but only 9% of injuries sustained in legal play. Conclusions: In comparison with other collision sports, research evaluating concussion in rugby league is limited. With such limited published rugby league data, there are many aspects of concussion that require attention, and future research may be directed towards these unanswered questions.

DOI10.1136/bjsports-2013-093102
CitationsScopus - 1
Co-authorsChris Levi
2015Gelder BM, Loughland CM, Carr VJ, Schofield PW, 'Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia', Acta Neuropsychiatrica, (2015)

Objective: This study investigated the ability of the Audio Recorded Cognitive Screen (ARCS) to detect cognitive deficit in individuals with schizophrenia, relative to the Mini Mental State Examination (MMSE) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and explored the associations between the ARCS and functional outcomes. We hypothesised that the ARCS would be able to better discriminate between individuals with schizophrenia and healthy controls than the MMSE, and that ARCS performance would be correlated with measures of social and vocational functioning. Methods: The participants were 19 community-dwelling individuals with schizophrenia or schizoaffective disorder and 19 healthy controls recruited from the Australian Schizophrenia Research Bank (ASRB). Participants completed the ARCS, MMSE, and self-report measures of social and vocational functioning. Clinical and diagnostic data stored by the ASRB were also utilised. Results: The schizophrenia group performed worse than the control group on the ARCS, with memory, t(36)=2.49, p=0.02, 95% CI [-1.84, -18.79] and fluency, t(36)=2.40, p=0.02, 95% CI [-1.87, -22.24] domains being the main discriminating measures. The RBANS also discriminated between the two groups, and ARCS and RBANS total scores were moderately to strongly correlated. There was no difference between the two groups on the MMSE after controlling for demographic variables. ARCS performance was associated with employment status [¿2(1)=7.16, p=0.007]. Conclusion: The ARCS may be sensitive to the cognitive deficits in outpatients with schizophrenia and an indicator of functional outcomes in this population.

DOI10.1017/neu.2015.19
Co-authorsCarmel Loughland
2015Ibrahim-Verbaas CA, Bressler J, Debette S, Schuur M, Smith AV, Bis JC, et al., 'GWAS for executive function and processing speed suggests involvement of the CADM2 gene.', Mol Psychiatry, (2015)
DOI10.1038/mp.2015.37Author URL
Co-authorsLiz Holliday, John Attia
2014Schofield PW, Finnie S, Yong YM, 'The role of olfactory challenge tests in incipient dementia and clinical trial design', Current neurology and neuroscience reports, 14 479-479 (2014) [C1]

The brain changes associated with Alzheimer's disease (AD) develop slowly over many years before the onset of dementia. Biomarkers for AD that allow its detection during this clinically silent phase will be hugely important when disease-modifying treatments that halt or slow its progression become available. Early detection, leading to early treatment, may in some cases avert dementia. Biomarkers aid our understanding of the presymptomatic stages of the disease and enable the identification of individuals with early disease who, by participating in clinical trials of investigational treatments with disease-modifying potential, contribute unique and vital information necessary to evaluate novel therapies. Most currently available AD biomarkers are expensive and not widely available and there are major efforts underway to find cheaper, simpler options. The olfactory system is affected by AD and the results from simple and inexpensive tests of the sense of smell, especially when paired with other information, can help identify individuals early in the disease. We review recent literature relevant to the use of simple olfactory tests, including some novel approaches, as aids to the early detection of AD. We consider their possible role in the design and conduct of clinical trials and suggest how in the future, when more effective treatments become available, they might be integrated into screening programs for early AD detection.

DOI10.1007/s11910-014-0479-z
2014Zahodne LB, Schofield PW, Farrell MT, Stern Y, Manly JJ, 'Bilingualism Does Not Alter Cognitive Decline or Dementia Risk Among Spanish-Speaking Immigrants', NEUROPSYCHOLOGY, 28 238-246 (2014) [C1]
DOI10.1037/neu0000014Author URL
CitationsScopus - 13Web of Science - 14
2014Oldmeadow C, Holliday EG, McEvoy M, Scott R, Kwok JBJ, Mather K, et al., 'Concordance between direct and imputed APOE genotypes using 1000 genomes data', Journal of Alzheimer's Disease, 42 391-393 (2014) [C1]

There are a growing number of large cohorts of older persons with genome-wide genotyping data available, but APOE is not included in any of the common microarray platforms. We compared directly measured APOE genotypes with those imputed using microarray data and the '1000 Genomes' dataset in a sample of 320 Caucasians. We find 90% agreement for e2/e3/e4 genotypes and 93% agreement for predicting e4 status, yielding kappa values of 0.81 and 0.84, respectively. More stringent thresholds around allele number estimates can increase this agreement to 90-97% and kappas of 0.90-0.93.

DOI10.3233/JAD-140846
Co-authorsJohn Attia, Rodney Scott, Christopher Oldmeadow, Liz Holliday
2014Schofield PW, Finnie S, Yong YM, 'The Role of Olfactory Challenge Tests in Incipient Dementia and Clinical Trial Design', Current Neurology and Neuroscience Reports, 14 (2014) [C1]

The brain changes associated with Alzheimer's disease (AD) develop slowly over many years before the onset of dementia. Biomarkers for AD that allow its detection during this clinically silent phase will be hugely important when disease-modifying treatments that halt or slow its progression become available. Early detection, leading to early treatment, may in some cases avert dementia. Biomarkers aid our understanding of the presymptomatic stages of the disease and enable the identification of individuals with early disease who, by participating in clinical trials of investigational treatments with disease-modifying potential, contribute unique and vital information necessary to evaluate novel therapies. Most currently available AD biomarkers are expensive and not widely available and there are major efforts underway to find cheaper, simpler options. The olfactory system is affected by AD and the results from simple and inexpensive tests of the sense of smell, especially when paired with other information, can help identify individuals early in the disease. We review recent literature relevant to the use of simple olfactory tests, including some novel approaches, as aids to the early detection of AD. We consider their possible role in the design and conduct of clinical trials and suggest how in the future, when more effective treatments become available, they might be integrated into screening programs for early AD detection. © 2014 Springer Science+Business Media New York.

DOI10.1007/s11910-014-0479-z
CitationsScopus - 2Web of Science - 2
2014McEvoy M, Schofield P, Smith W, Agho K, Mangoni AA, Soiza RL, et al., 'Memory Impairment is Associated with Serum Methylarginines in Older Adults', CURRENT ALZHEIMER RESEARCH, 11 97-106 (2014) [C1]
Author URL
CitationsScopus - 2Web of Science - 2
Co-authorsJohn Attia, Roseanne Peel
2014Gardner A, Iverson GL, Levi CR, Schofield PW, Kay-Lambkin F, Kohler RMN, Stanwell P, 'A systematic review of concussion in rugby league', British Journal of Sports Medicine, (2014)

Objectives Concussion remains one of the inherent risks of participation in rugby league. While other injuries incurred by rugby league players have been well studied, less focus and attention has been directed towards concussion. Review method The current review examined all articles published in English from 1900 up to June 2013 pertaining to concussion in rugby league players. Data sources Publications were retrieved via six databases using the key search terms: rugby league, league, football; in combination with injury terms: athletic injuries, concussion, sports concussion, sports-related concussion, brain concussion, brain injury, brain injuries, mild traumatic brain injury, mTBI, traumatic brain injury, TBI, craniocerebral trauma, head injury and brain damage. Observational, cohort, correlational, cross-sectional and longitudinal studies were all included. Results 199 rugby league injury publications were identified. 39 (20%) were related in some way to concussion. Of the 39 identified articles, 6 (15%) had the main aim of evaluating concussion, while the other 33 reported on concussion incidence as part of overall injury data analyses. Rugby league concussion incidence rates vary widely from 0.0 to 40.0/1000 playing hours, depending on the definition of injury (time loss vs no time loss). The incidence rates vary across match play versus training session, seasons (winter vs summer) and playing position (forwards vs backs). The ball carrier has been found to be at greater risk for injury than tacklers. Concussion accounts for 29% of all injuries associated with illegal play, but only 9% of injuries sustained in legal play. Conclusions In comparison with other collision sports, research evaluating concussion in rugby league is limited. With such limited published rugby league data, there are many aspects of concussion that require attention, and future research may be directed towards these unanswered questions. © 2014 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine.

DOI10.1136/bjsports-2013-093102
CitationsWeb of Science - 2
Co-authorsF Kaylambkin, Chris Levi
2014Napthali K, Boyle M, Tran H, Schofield PW, Peel R, McEvoy M, et al., 'Thyroid antibodies, autoimmunity and cognitive decline: is there a population-based link?', Dement Geriatr Cogn Dis Extra, 4 140-146 (2014) [C1]
DOI10.1159/000362716Author URL
Co-authorsChristopher Oldmeadow, Roseanne Peel, John Attia
2014Schofield PW, Moore TM, Gardner A, 'Traumatic brain injury and olfaction: A systematic review', Frontiers in Neurology, 5 JAN (2014) [C1]

Traumatic brain injury (TBI) is a common condition that is often complicated by neuropsychiatric sequelae that can have major impacts on function and quality of life. An alteration in the sense of smell is recognized as a relatively common complication of TBI; however in clinical practice, this complication may not be sought or adequately characterized. We conducted a systematic review of studies concerned with olfactory functioning following TBI. Our predetermined criteria led to the identification of 25 studies published in English, which we examined in detail. We have tabulated the data from these studies in eight separate tables, beginning with Table 1, which highlights each study's key findings, and we provide a summary/synthesis of the findings in the accompanying results and discussion sections. Despite widely differing methodologies, the studies attest to a high frequency of post-TBI olfactory dysfunction and indicate that its presence can serve as a potential marker of additional structural or functional morbidities. © 2014 Schofield, Moore and Gardner.

DOI10.3389/fneur.2014.00005
CitationsScopus - 2
2013Gunathilake R, Oldmeadow C, McEvoy M, Kelly B, Inder K, Schofield P, Attia J, 'Mild Hyponatremia Is Associated With Impaired Cognition And Falls In Community-Dwelling Older Persons', Journal of the American Geriatrics Society, 61 1838-1839 (2013) [C1]
DOI10.1111/jgs.12468Author URL
CitationsScopus - 7Web of Science - 7
Co-authorsJohn Attia, Brian Kelly, Christopher Oldmeadow, Kerry Inder
2013Debette S, Ibrahim Verbaas CA, Bressler J, Schuur M, Smith A, Bis JC, et al., 'Genome-wide Studies of Verbal Declarative Memory in Nondemented Older People: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium', Biological Psychiatry, (2013)

Background: Memory performance in older persons can reflect genetic influences on cognitive function and dementing processes. We aimed to identify genetic contributions to verbal declarative memory in a community setting. Methods: We conducted genome-wide association studies for paragraph or word list delayed recall in 19 cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, comprising 29,076 dementia- and stroke-free individuals of European descent, aged =45 years. Replication of suggestive associations (p < 5 × 10-6) was sought in 10,617 participants of European descent, 3811 African-Americans, and 1561 young adults. Results: rs4420638, near APOE, was associated with poorer delayed recall performance in discovery (p = 5.57 × 10-10) and replication cohorts (p = 5.65 × 10-8). This association was stronger for paragraph than word list delayed recall and in the oldest persons. Two associations with specific tests, in subsets of the total sample, reached genome-wide significance in combined analyses of discovery and replication (rs11074779 [HS3ST4], p = 3.11 × 10-8, and rs6813517 [SPOCK3], p = 2.58 × 10-8) near genes involved in immune response. A genetic score combining 58 independent suggestive memory risk variants was associated with increasing Alzheimer disease pathology in 725 autopsy samples. Association of memory risk loci with gene expression in 138 human hippocampus samples showed cis-associations with WDR48 and CLDN5, both related to ubiquitin metabolism. Conclusions: This largest study to date exploring the genetics of memory function in ~40,000 older individuals revealed genome-wide associations and suggested an involvement of immune and ubiquitin pathways.

DOI10.1016/j.biopsych.2014.08.027
Co-authorsLiz Holliday, John Attia, Christopher Oldmeadow
2013McEvoy MA, Schofield P, Smith W, Agho K, Mangoni AA, Soiza RL, et al., 'Serum methylarginines and incident depression in a cohort of older adults', Journal of Affective Disorders, 151 493-499 (2013) [C1]
DOI10.1016/j.jad.2013.06.033Author URL
CitationsScopus - 2Web of Science - 2
Co-authorsKerry Inder, Brian Kelly, John Attia, Roseanne Peel
2013McEvoy MA, Schofield PW, Smith WT, Agho K, Mangoni AA, Soiza RL, et al., 'Serum Methylarginines and Spirometry-Measured Lung Function in Older Adults', PLOS ONE, 8 (2013) [C1]
DOI10.1371/journal.pone.0058390Author URL
Co-authorsJohn Attia, Wayne Smith, Roseanne Peel
2012Reid MG, Parkinson L, Gibson RE, Schofield PW, D'Este CA, Attia JR, et al., 'Memory Complaint Questionnaire performed poorly as screening tool: Validation against psychometric tests and affective measures', Journal of Clinical Epidemiology, 65 199-205 (2012) [C1]
CitationsScopus - 9Web of Science - 9
Co-authorsL Parkinson, Catherine Deste, Julie Byles, John Attia, Meredith Tavener
2012Gardner AJ, Kay-Lambkin FJ, Stanwell PT, Donnelly J, Williams WH, Hiles A, et al., 'A systematic review of diffusion tensor imaging findings in sports-related concussion', Journal of Neurotrauma, 29 2521-2538 (2012) [C1]
CitationsScopus - 25Web of Science - 20
Co-authorsF Kaylambkin, Chris Levi
2012Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR, 'An olfactory 'stress test' may detect preclinical Alzheimer's disease', BMC Neurology, 12 1-8 (2012) [C1]
CitationsScopus - 14Web of Science - 14
2012Huang L, Chardon JW, Carter MT, Friend KL, Dudding TE, Schwartzentruber J, et al., 'Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia', Orphanet Journal of Rare Diseases, 7 67 (2012) [C1]
CitationsScopus - 14Web of Science - 13
2011Schofield PW, Butler T, Hollis S, D'Este CA, 'Are prisoners reliable survey respondents? A validation of self-reported traumatic brain injury (TBI) against hospital medical records', Brain Injury, 25 74-82 (2011) [C1]
DOI10.3109/02699052.2010.531690
CitationsScopus - 15Web of Science - 12
Co-authorsCatherine Deste
2011Perkes IE, Schofield PW, Butler T, Hollis SJ, 'Traumatic brain injury rates and sequelae: A comparison of prisoners with a matched community sample in Australia', Brain Injury, 25 131-141 (2011) [C1]
DOI10.3109/02699052.2010.536193
CitationsScopus - 6Web of Science - 5
2010Butler T, Schofield PW, Greenberg D, Allnutt SH, Indig D, Carr V, et al., 'Reducing impulsivity in repeat violent offenders: An open label trial of a selective serotonin reuptake inhibitor', Australian and New Zealand Journal of Psychiatry, 44 1137-1143 (2010) [C1]
DOI10.3109/00048674.2010.525216
CitationsScopus - 14Web of Science - 12
Co-authorsCatherine Deste
2010Schofield PW, Lee SJ, Lewin TJ, Lyall G, Moyle J, Attia JR, McEvoy MA, 'The Audio Recorded Cognitive Screen (ARCS): A flexible hybrid cognitive test instrument', Journal of Neurology Neurosurgery and Psychiatry, 81 602-607 (2010) [C1]
DOI10.1136/jnnp.2009.188003
CitationsScopus - 12Web of Science - 10
Co-authorsTerry Lewin, John Attia
2010McEvoy MA, Smith WT, D'Este CA, Duke JM, Peel R, Schofield PW, et al., 'Cohort Profile: The Hunter Community Study', International Journal of Epidemiology, 39 1452-1463 (2010) [C1]
DOI10.1093/ije/dyp343
CitationsScopus - 52Web of Science - 51
Co-authorsCatherine Deste, Wayne Smith, Ben Ewald, Julie Byles, Roseanne Peel, Rodney Scott, Derek Smith, Mddah01, John Attia
2010Loughland CM, Allen J, Gianacas L, Schofield PW, Lewin TJ, Hunter M, Carr VJ, 'Brief neuropsychological profiles in psychosis: A pilot study using the Audio Recorded Cognitive Screen (ARCS)', Acta Neuropsychiatrica, 22 243-252 (2010) [C1]
DOI10.1111/j.1601-5215.2010.00492.x
CitationsScopus - 4Web of Science - 3
Co-authorsCarmel Loughland, Mick Hunter, Terry Lewin
2010Lechner-Scott J, Kerr T, Spencer B, Agland S, Lydon A, Schofield PW, 'The audio recorded cognitive screen (ARCS) in patients with multiple sclerosis: A practical tool for multiple sclerosis clinics', Multiple Sclerosis, 16 1126-1133 (2010) [C1]
DOI10.1177/1352458510374743
CitationsScopus - 6Web of Science - 4
2008Bateman GA, Levi CR, Schofield PW, Wang Y, Lovett EC, 'The venous manifestations of pulse wave encephalopathy: Windkessel dysfunction in normal aging and senile dementia', Neuroradiology, 50 491-497 (2008) [C1]
DOI10.1007/s00234-008-0374-x
CitationsScopus - 34Web of Science - 30
Co-authorsChris Levi
2006Schofield PW, Gibson RE, Tavener MA, Attia JR, D'Este CA, Guest M, et al., 'Neuropsychological health in F-111 aircraft maintenance workers', NeuroToxicology, 27 852-860 (2006) [C1]
DOI10.1016/j.neuro.2006.02.002
CitationsScopus - 11Web of Science - 11
Co-authorsCatherine Deste, John Attia, Maya Guest, Meredith Tavener
2006Schofield PW, Butler TG, Hollis SJ, Smith NE, Lee SJ, Kelso WM, 'Traumatic brain injury among Australian prisoners: Rates, recurrence and sequelae', Brain Injury, 20 499-506 (2006) [C1]
DOI10.1080/02699050600664749
CitationsScopus - 28Web of Science - 24
2006Schofield PW, Butler TG, Hollis SJ, Smith NE, Stephen L, Wendy K, 'Neuropsychiatric correlates of traumatic brain injury (TBI) among Australian prison entrants', Brain Injury, 20 1409-1418 (2006) [C1]
DOI10.1080/02699050601130443
CitationsScopus - 22Web of Science - 22
2006Bateman GA, Levi CR, Schofield PW, Wang Y, Lovett EC, 'Quantitative measurement of cerebral haemodynamics in early vascular dementia and Alzheimer's disease', Journal of Clinical Neuroscience, 13 563-568 (2006) [C1]
DOI10.1016/j.jocn.2005.04.017
CitationsScopus - 29Web of Science - 24
Co-authorsChris Levi
2006Attia JR, D'Este CA, Schofield PW, Brown AM, Gibson RE, Tavener MA, et al., 'Mental health in F-111 maintenance workers: the study of Health Outcomes in Aircraft Maintenance Personnel (SHOAMP) general health and medical study', Journal of Occupational and Environmental Medicine, 48 682-691 (2006) [C1]
DOI10.1097/01.jom.0000205985.00559.84
CitationsScopus - 11Web of Science - 10
Co-authorsCatherine Deste, John Attia, Meredith Tavener
2005Attia J, Schofield P, 'What now for Alzheimer's disease? An epidemiological evaluation of the AD2000 trial', Australian Prescriber, 28 134-135 (2005)
CitationsScopus - 1
Co-authorsJohn Attia
2005Attia JR, Schofield PW, 'What now for Alzheimer's disease? An epidemiological evaluation of the AD2000 trial', Australian Prescriber, 28 2-3 (2005) [C3]
2005Schofield PW, James K, Lee S, Kelso W, Lowe J, Poole L, et al., 'Homocysteine and Cognition in People with Type 2 Diabetes', Journal of Neurological Sciences, 238 1662 (2005) [C3]
2005Bateman GA, Levi CR, Schofield PW, Wang Y, Lovett EC, 'The pathophysiology of the aqueduct stroke volume in normal pressure hydrocephalus:can co-morbidity with other forms of dementia be excluded', Neuroradiology, 47 741-748 (2005) [C1]
DOI10.1007/s00234-005-1418-0
CitationsScopus - 40Web of Science - 32
Co-authorsChris Levi
2005Schofield PW, 'Dementia associated with toxic causes and autoimmune disease', International Psychogeriatrics, 17 S129-S147 (2005) [C1]
DOI10.1017/S1041610205001997
CitationsScopus - 12Web of Science - 7
2004Dudding TE, Friend K, Schofield PW, Lee SJ, Wilkinson IA, Richards R, 'Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus', Neurology, 63 2288-2292 (2004) [C1]
DOI10.1212/01.WNL.0000147299.80872.D1
CitationsScopus - 36Web of Science - 30
2004Schofield PW, Lee S, 'Home based testing of cognition with the tape administered cognitive screen', Neurobiology of Aging, 25 S122 (2004) [C3]
2003Schofield PW, Lee S, Davies G, 'Cognitive screening using a tape recorder: a pilot study', Journal of the American Geriatrics Society, 51 415-418 (2003) [C1]
DOI10.1046/j.1532-5415.2003.51118.x
CitationsScopus - 4Web of Science - 1
2003Stanford P, Shepherd C, Halliday G, Brooks W, Schofield PW, Brodaty H, et al., 'Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia', Brain, 126 814-826 (2003) [C1]
DOI10.1093/brain/awg090
CitationsScopus - 72Web of Science - 68
2000Byles JE, Higginbotham HN, Goodger BG, Tavener MA, Conrad A, Schofield P, Anthony DM, 'Development of a depression scale for veterans and war widows', International Journal of Behavioral Medicine, 7 256-270 (2000) [C1]
CitationsScopus - 4Web of Science - 3
Co-authorsJulie Byles, Meredith Tavener, Nick Higginbotham
1999Schofield P, 'Alzheimer's disease and brain reserve', AUSTRALASIAN JOURNAL ON AGEING, 18 10-14 (1999)
DOI10.1111/j.1741-6612.1999.tb00081.xAuthor URL
CitationsWeb of Science - 13
1999Devi G, Marder K, Schofield P, Tang M, Stern Y, Mayeux R, 'Validity of family history diagnosis for dementia - Reply', GENETIC EPIDEMIOLOGY, 17 152-154 (1999)
Author URL
1999Schofield PW, 'Alzheimer's disease and brain reserve', Australasian journal of ageing, 18 10-14 (1999) [C3]
1998Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, et al., 'Cognitive function in nondemented older women who took estrogen after menopause', NEUROLOGY, 50 368-373 (1998)
Author URL
CitationsWeb of Science - 232
1998Devi G, Marder K, Schofield PW, Tang MX, Stern Y, Mayeux R, 'Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease', GENETIC EPIDEMIOLOGY, 15 215-223 (1998)
DOI10.1002/(SICI)1098-2272(1998)15:3<215::AID-GEPI1>3.0.CO;2-3Author URL
CitationsScopus - 18Web of Science - 19
1998Stern Y, Tang MX, Jacobs DM, Marder K, Bell K, Dooneief G, et al., 'Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia', JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 4 279-284 (1998)
Author URL
CitationsWeb of Science - 21
1997Jacobs DM, Sano M, Albert S, Schofield P, Dooneief G, Stern Y, 'Cross-cultural neuropsychological assessment: A comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults', JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 19 331-339 (1997)
DOI10.1080/01688639708403862Author URL
CitationsScopus - 60Web of Science - 57
1997Schofield PW, Jacobs D, Marder K, Sano M, Marder K, Stern Y, 'The validity of new memory complaints in the elderly', Archives of Neurology, 54 756-759 (1997)
1997Schofield PW, Stern Y, Tan M-X, Jacobs DM, Sano M, Marder K, et al., 'Prospective comparative study of the evolution of probable Alzheimer¿s disease and Parkinson¿s disease dementia', Neurology, 48 . (1997)
1997Schofield PW, Tang M-X, Stern Y, Tycho B, Mayeux R, 'Incidence of Alzheimer Disease by APOE Genotype among elderly', Neurology, 48 . (1997)
1997Albert SM, Marder K, Schofield P, Bell K, Gurland B, Stern Y, Mayeux R, 'Disability-free life expectancy in Alzheimer's disease.', AMERICAN JOURNAL OF EPIDEMIOLOGY, 145 314-314 (1997)
Author URL
1997Schofield PW, Marder M, Dooneief G, Jacobs DM, Sano M, Stern Y, 'Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment', AMERICAN JOURNAL OF PSYCHIATRY, 154 609-615 (1997)
Author URL
CitationsScopus - 150Web of Science - 136
1997Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, et al., 'Alzheimer's disease after remote head injury: An incidence study', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 62 119-124 (1997)
DOI10.1136/jnnp.62.2.119Author URL
CitationsScopus - 132Web of Science - 123
1997Schofield PW, Logroscino G, Andrews HF, Albert S, Stern Y, 'An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia', NEUROLOGY, 49 30-37 (1997)
Author URL
CitationsScopus - 116Web of Science - 105
1996Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, et al., 'Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City', AMERICAN JOURNAL OF HUMAN GENETICS, 58 574-584 (1996)
Author URL
CitationsScopus - 113Web of Science - 119
1996Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, et al., 'A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease', NEUROLOGY, 47 256-259 (1996)
Author URL
CitationsScopus - 83Web of Science - 79
1996Marder K, Albert S, Dooneief G, Stern Y, Ramachandran G, Todak G, et al., 'Clinical confirmation of the American Academy of Neurology algorithm for HIV-associated cognitive/motor disorder', NEUROLOGY, 47 1247-1253 (1996)
Author URL
CitationsWeb of Science - 96
1996Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al., 'Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease', LANCET, 348 429-432 (1996)
DOI10.1016/S0140-6736(96)03356-9Author URL
CitationsWeb of Science - 1186
1996Schofield PW, 'The Dana Consortium on therapy for HIV Dementia and Related Disorders', Neurology, 47 1247-1253 (1996)
1995SCHOFIELD PW, MOSESSON RE, STERN Y, MAYEUX R, 'THE AGE AT ONSET OF ALZHEIMERS-DISEASE AND AN INTRACRANIAL AREA MEASUREMENT - A RELATIONSHIP', ARCHIVES OF NEUROLOGY, 52 95-98 (1995)
Author URL
CitationsScopus - 76Web of Science - 71
1995MARDER K, LIU X, STERN Y, DOONEIEF G, BELL K, SCHOFIELD P, et al., 'NEUROLOGIC SIGNS AND SYMPTOMS IN A COHORT OF HOMOSEXUAL MEN FOLLOWED FOR 4.5 YEARS', NEUROLOGY, 45 261-267 (1995)
Author URL
CitationsScopus - 20Web of Science - 22
1995Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Lantigua R, et al., 'Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease', NEUROLOGY, 45 2159-2164 (1995)
Author URL
CitationsScopus - 25Web of Science - 21
Show 63 more journal articles

Conference (44 outputs)

YearCitationAltmetricsLink
2014Ribbons K, Schofield P, Lea RA, Caruana P, Agland S, Lechner-Scott J, 'Cognitive impairment as measured by Audio Recorded Cognitive Screen in an MS clinic population with up to 6 years follow up', MULTIPLE SCLEROSIS JOURNAL, Boston, MA (2014) [E3]
Author URL
2014Graves MC, Ribbons K, Lea R, Vucic S, Shaw CP, Broadley S, et al., 'Do disease modifying treatments affect cognitive performance in early multiple sclerosis?', MULTIPLE SCLEROSIS JOURNAL, Boston, MA (2014) [E3]
Author URL
2014Saleem TA, Mcdonald M, Sankaranarayanan A, Schofield P, Wark P, 'PREVALENCE AND IMPACT OF COGNITIVE IMPAIRMENT IN COPD', RESPIROLOGY (2014) [E3]
Author URL
2014Mather KA, Thalamuthu A, Oldmeadow C, Song F, Armstrong NJ, Poljak A, et al., 'Genome-wide significant results identified for plasma apolipoprotein h levels', Alzheimer's & Dementia (2014) [E3]
DOI10.1016/j.jalz.2014.05.1526
Co-authorsJohn Attia, Liz Holliday, Rodney Scott, Christopher Oldmeadow
2013Schofield PW, Butler T, 'Traumatic brain injury and offending: cause or confound', ., Sydney, NSW (2013) [E3]
2013Schofield PW, Moore T, Lewin T, Kerr T, McRae S, Gardner A, 'The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested', Alzheimer's and Dementia, Boston, MA (2013) [E3]
2013Schofield PW, Moore T, Finnie S, Ebrahimi H, 'Olfactory stress test (OST) performance in cognitively normal elders is associated with apolipoprotein E (APOE) genotype', Alzheimer's and Dementia, Boston, MA (2013) [E3]
2013Schofield PW, Moore T, Lewin T, Kerr T, McRae S, Gardner A, Babu U, 'Repeat testing with the Audio Recorded Cognitive Screen (ARCS) in an outpatient clinic', Alzheimer's and Dementia, Boston, MA (2013) [E3]
2013Finnie S, Schofield P, Savage G, Ebrahaimi H, Moore T, 'Development of a cholinergic biomarker for Alzheimer¿s disease: Control data from a modified Olfactory Stress Test', Neurodegenerative Diseases, Florence (2013) [E3]
2012Ribbons KA, Agland S, Schofield P, Brown K, McElduff P, Lechner-Scott J, 'Disease modifying multiple sclerosis treatments improve cognitive function in a routine clinical setting', MULTIPLE SCLEROSIS JOURNAL, Melbourne, AUSTRALIA (2012) [E3]
Author URL
2010Schofield PW, 'A cognitive profile in less than 5 minutes of clinician time?', Alzheimer's and Dementia, Honolulu, HA (2010) [E3]
2010Schofield PW, Murray S, Jones A, Bateman G, Walsh B, 'An ¿Olfactory Stress Test¿ for detection of preclinical Alzheimer¿s disease', Alzheimer's and Dementia, Honolulu, HA (2010) [E3]
2009Schofield PW, Lee SJ, Lyall G, 'Symptoms of apathy and depression and the validity of the Audio Recorded Cognitive Screen (ARCS)', Alzheimer's and Dementia, Vienna, Austria (2009) [E3]
2009Schofield PW, Lyall G, Lee S, 'The ARCS: A One Minute 47 Second Cognitive Screen', Journal of Clinical Neuroscience, . (2009) [E3]
2009Schofield PW, Perkes I, Butler T, 'High rates of past traumatic brain injury both in prisoners and appropriate controls', Journal of Neuropsychiatry and Clinical Neurosciences, San Francisco, CA (2009)
2009Lechner-Scott J, Kerr T, Agland S, Lydon A, Schofield P, 'Audio recorded cognitive screening: new tool to assess cognitive impairment in the clinical setting', Multiple Sclerosis, Dusseldorf, Germany (2009) [E3]
2009Schofield PW, Moyle J, Bell A, Carnovale M, Attia K, Drysdale K, 'The Audio Recorded Cognitive Screen (ARCS): comparison against formal neuropsychological assessment', The Journal of Neuropsychiatry & Clinical Neurosciences, San Francisco, CA (2009)
2008Schofield PW, Lee SJ, Lyall G, Zunong RN, Kwan EY, 'The ARCS: A hybrid cognitive test instrument, highly efficient for the clinician', Alzheimer's and Dementia, Chicago, IL (2008) [E3]
2008Schofield PW, Butler T, 'Traumatic brain injury and the criminal justice system', ., Melbourne (2008) [E3]
2008Schofield PW, Lee S, Lyall G, 'The ARCS: a one minute 47 second cognitive screen', n/a, Chicago, IL (2008) [E3]
2006D'Este C, Attia J, Brown A, Schofield P, Tavener M, Gibson R, Horsley K, 'SHOAMP: The study of health outcomes in aircraft maintenance personnel.', NEUROTOXICOLOGY, Res Triangle Park, NC (2006)
Author URL
Co-authorsCatherine Deste, John Attia
2006Schofield PW, Lee SJ, Wm K, Lyall G, 'Memory testing using the audio recorded cognitive screen (ARCS): concurrent validity', Neuropsychiatric Disease and Treatment, Sydney (2006) [E3]
2006Schofield PW, Butler T, Hollis S, Lee SJ, Wm K, 'Validation of self-reported past traumatic brain injury in a prisoner population', Neuropsychiatric Disease and Treatment, Sydney Australia (2006) [E3]
2006Schofield PW, 'Brain Reserve: Theoretical constructs and the epidemiological evidence', Neuropsychiatric Disease and Treatment, Sydeny Australia (2006) [E3]
2006Schofield PW, Lee SJ, Wm K, Lyall G, 'A novel test of executive functioning within the Audio recorded cognitive screen (ARCS): concurrent validity', Neuropsychiatric Disease and Treatment, Sydney Australia (2006) [E3]
2006Schofield PW, Maggie P, Matt T, Dp D, Pelton GH, Yaakov S, 'Correlates of Subjective Memory cmplaints ina clinical sample: relationship to level of impairment', Alzheimer's & Dementia, Madrid (2006) [E3]
2005Schofield PW, James K, Lee S, Kelso W, Lowe J, Poole L, et al., 'Homocysteine and cognition in people with type 2 diabetes', JOURNAL OF THE NEUROLOGICAL SCIENCES, Sydney, AUSTRALIA (2005)
Author URL
2005Schofield PW, 'Discrepancies in cognitive history from patients and informants in relation to cognitive function', Alzheimer's and Dementia, New York (2005) [C3]
2005Lee SJ, Kelso W, Schofield PW, Butler T, Hollis S, 'Traumatic brain injury and its correlates among the Australian prison entrants', Public Health Association of Australia Conference, - (2005) [E3]
2004Schofield PW, Stephen L, 'Home-based testing of cognition with the tape-administered cognitive screen', NEUROBIOLOGY OF AGING, Philadelphia, PA (2004)
DOI10.1016/S0197-4580(04)80435-4Author URL
CitationsWeb of Science - 2
2004Schofield PW, Lee S, 'Sensitive detection of mild cognitive impairment using a tape-administered cognitive screen', Journal of Neuropsychiatry and Clinical Neurosciences, Washington, D.C. (2004) [C3]
2004Schofield PW, Lee S, 'Tape administered cognitive screen: receiver operating characteristics in a memory disorders clinic sample', Neurobiology of Aging, New York (2004) [C3]
2003Schofield PW, Lee S, James K, Davies G, 'Screening for cognitive impairment at a diabetes education program: advantages of group testing using a novel screening instrument', ., Melbourne (2003)
2003Schofield PW, James K, Lee S, 'Correlates of subjective memory complaints among diabetics attending a diabetes education centre', ADS-ADEA Annual Scientific Conference, - (2003) [E3]
1997Albert SA, Marder K, Schofield P, Bell K, Gurland B, Stern Y, Mayeux R, 'Disability-free life expectancy in Alzheimer¿s Disease: results from a population-based survey', Neurology, . (1997)
1997Stern Y, Tang M-X, Jacobs DM, Sano M, Marder K, Bell K, et al., 'Prospective comparative study of the evolution of probable Alzheimer¿s disease and Parkinson¿s disease dementia', Neurology, . (1997)
1997Tang M-X, Stern Y, Tycho B, Schofield P, Mayeux R, 'Incidence of Alzheimer Disease by APOE Genotype among elderly African Americans, Caucasians and Hispanics in New York City', Neurology, . (1997)
1996Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, et al., 'Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease', APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE, CHICAGO, IL (1996)
DOI10.1111/j.1749-6632.1996.tb32593.xAuthor URL
CitationsScopus - 63Web of Science - 61
1996Schofield PW, Albert S, Stern Y, Mayeux R, 'An association between head circumference and Alzheimer's disease', Neuroepidemiology, . (1996)
1996Schofield PW, Marder K, Dooneief G, Bell K, Chun M, Ramachandran G, et al., 'Subjective memory complaints predict decline in cognitively impaired, but not cognitively normal subjects', Neurology, Vancouver, Canada (1996)
1996Tang M-X, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, et al., 'Relative risk of Alzheimer's disease and age-at-onset distributions based on Apolipoprotein E genotypes among elderly African Americans, Caucasians, and Hispanics in New York City', Neurology, . (1996)
1994Schofield PW, Chun M, Sacktor N, Denaro J, Marder K, Bell K, et al., 'Frequencies and causes of cognitive impairment and dementia in a community-based registry', Neurology (1994)
1994Marder K, Lui X, Stern Y, Dooneief G, Bell K, Schofield P, et al., 'Neurological signs and symptoms in a cohort of 4.5 years', Neuroscience of HIV Infection Basic and Clinical Frontiers, Vancouver (1994)
1976Schofield PW, Westerman RA, Prochazka A, '"Gain" of the functional stretch reflex in humans-its dependence on the level of muscle tone', Proceedings of the A.P.P.S., . (1976)
Show 41 more conferences

Report (1 outputs)

YearCitationAltmetricsLink
2004D''Este C, Attia JR, Brown A, Byles J, Schofield P, Gibberd RG, Lee S, 'Study of health of aircraft maintenance personnel', Department of Defence and Department of Veteran''s Affairs (2004) [R1]
Edit

Grants and Funding

Summary

Number of grants26
Total funding$5,849,377

Click on a grant title below to expand the full details for that specific grant.


20141 grants / $272,394

The relationship between mental illness and offending in New South Wales$272,394

Discovery Project
Funding body: Mental Health Commission of New South Wales

Funding bodyMental Health Commission of New South Wales
Project Team
SchemeUnknown
RoleLead
Funding Start2014
Funding Finish2015
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20132 grants / $2,522,093

The Australian Centre for Research Excellence in Offender Health$2,494,581

&nbsp;
Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project Team
SchemeProject Grant
RoleInvestigator
Funding Start2013
Funding Finish2014
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Mild traumatic brain injury (TBI) and violence: an opportunity for Intervention$27,512

Funding body: John Hunter Hospital Charitable Trust Fund

Funding bodyJohn Hunter Hospital Charitable Trust Fund
Project Team
SchemeResearch Grant
RoleInvestigator
Funding Start2013
Funding Finish2014
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20123 grants / $855,587

An olfactory 'stress test' for early detection of Alzheimer's disease$756,087

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Associate Professor Peter Schofield, Professor John Attia, Professor Alison Jones, Conjoint Associate Professor Grant Bateman
SchemeProject Grant
RoleLead
Funding Start2012
Funding Finish2012
GNoG1100221
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

The Australian Centre for Research Excellence in Offender Health$98,500

Funding bodyUnknown
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2012
Funding Finish2013
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Plasma protein profiles in normal brain ageing and early stages of dementia$1,000

Funding body: ARC (Australian Research Council)

Funding bodyARC (Australian Research Council)
Project TeamProfessor Perminder Sachdev, Dr Anne Poljak, Professor John Attia, Conjoint Associate Professor Peter Schofield, Dr John Crawford, Professor Mark Duncan
SchemeDiscovery Projects
RoleInvestigator
Funding Start2012
Funding Finish2012
GNoG1200767
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

20113 grants / $395,000

Plasma protein profiles in normal brain ageing and early stages of dementia$330,000

Discovery Grant
Funding body: ARC (Australian Research Council)

Funding bodyARC (Australian Research Council)
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2011
Funding Finish2012
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Relationships between white matter lesions and cognitive and motor functioning in patients with minor ischaemic stroke: A structural and functional brain imaging study - RhD 2yr$40,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamMr Todd Jolly, Associate Professor Frini Karayanidis, Professor Mark Parsons, Conjoint Professor Chris Levi, Emeritus Professor Patricia Michie, Conjoint Associate Professor Grant Bateman, Conjoint Associate Professor Peter Schofield
SchemeResearch Higher Degree Support Grant
RoleInvestigator
Funding Start2011
Funding Finish2011
GNoG1100061
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

The Olfactory Stress Test in Down’s syndrome and cognitively normal controls: evidence for soluble amyloid deposition?$25,000

Funding body: John Hunter Hospital Charitable Trust Fund

Funding bodyJohn Hunter Hospital Charitable Trust Fund
Project Team
SchemeResearch Grant
RoleInvestigator
Funding Start2011
Funding Finish2012
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20102 grants / $1,316,000

Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Zoloft)$1,291,400

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2010
Funding Finish2013
GNo
Type Of FundingExternal
CategoryEXTE
UONY

A structural and functional brain imaging study of how white matter lesions in patients with minor ischaemic strike affect cognitive and motor control processes$24,600

Funding body: Hunter Children`s Research Foundation

Funding bodyHunter Children`s Research Foundation
Project TeamAssociate Professor Frini Karayanidis, Professor Mark Parsons, Emeritus Professor Patricia Michie, Conjoint Professor Chris Levi, Ms Sharna Jamadar, Mr Matthew Hughes, Conjoint Associate Professor Peter Schofield, Conjoint Associate Professor Grant Bateman
SchemeResearch Grant
RoleInvestigator
Funding Start2010
Funding Finish2010
GNoG0900150
Type Of FundingGrant - Aust Non Government
Category3AFG
UONY

20092 grants / $283,875

Does traumatic brain injury lead to offending?$267,175

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2009
Funding Finish2010
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Development of an olfactory stress test for the early identification of Alzheimer’s disease$16,700

Funding body: John Hunter Hospital Charitable Trust Fund

Funding bodyJohn Hunter Hospital Charitable Trust Fund
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2009
Funding Finish2010
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20082 grants / $66,000

Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline)$50,000

Funding body: NSW Health

Funding bodyNSW Health
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2008
Funding Finish2009
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Investigating the benefits of cognitive screening in people with diabetes$16,000

Funding body: Novo Nordisk Foundation

Funding bodyNovo Nordisk Foundation
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2008
Funding Finish2009
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20071 grants / $7,678

The impact of Asymmetrical Dimethylarginine on Cognition in a population-based cohort$7,678

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamMr Mark McEvoy, Conjoint Professor Wayne Smith, Conjoint Associate Professor Peter Schofield, Professor John Attia
SchemePilot Grant
RoleInvestigator
Funding Start2007
Funding Finish2007
GNoG0187872
Type Of FundingInternal
CategoryINTE
UONY

20062 grants / $25,500

The impact of Anticholinergic activity, apolipoprotein E and high-affinity choline transporter genotype on cognition in a population-based co-hort: a pilot study$15,500

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamMr Mark McEvoy, Conjoint Associate Professor Peter Schofield, Conjoint Professor Wayne Smith, Doctor Janine Duke, Professor John Attia
SchemeProject Grant
RoleInvestigator
Funding Start2006
Funding Finish2006
GNoG0186170
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

The impact of Anticholinergic Activity on cognition in a population-based cohort$10,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Associate Professor Peter Schofield, Conjoint Professor Wayne Smith, Conjoint Professor Ian Whyte, Conjoint Professor David Sibbritt, Mr Mark McEvoy
SchemeNear Miss Grant
RoleLead
Funding Start2006
Funding Finish2006
GNoG0186077
Type Of FundingInternal
CategoryINTE
UONY

20053 grants / $62,000

Relationship between traumatic brain injury and its sequelae and recidivism in soon to be released prisoners$50,000

Funding body: Ian Potter Foundation

Funding bodyIan Potter Foundation
Project Team
SchemeResearch Grant
RoleInvestigator
Funding Start2005
Funding Finish2006
GNo
Type Of FundingExternal
CategoryEXTE
UONY

A Validation and Normative Study of the Tape Administered Cognitive Screen, version 2 (TACS-II)$10,000

Funding body: CAPRA

Funding bodyCAPRA
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2005
Funding Finish2006
GNo
Type Of FundingExternal
CategoryEXTE
UONY

Pre-operative screening to identify patients at increased risk of adverse in-hopsital post-surgical outcomes$2,000

Funding body: Hunter Medical Research Institute (HMRI)

Funding bodyHunter Medical Research Institute (HMRI)
Project Team
SchemeResearch Grant
RoleInvestigator
Funding Start2005
Funding Finish2005
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20041 grants / $2,000

Pre-operative screening to identify patients at increased risk of adverse in-hospital post-surgical outcomes$2,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamConjoint Associate Professor Peter Schofield, Dr R Kerridge
SchemeResearch Grant
RoleLead
Funding Start2004
Funding Finish2004
GNoG0183768
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

20021 grants / $15,000

Assessment of cerebrovascular compliance in cognitively impaired patients$15,000

Funding body: Australian Brain Foundation

Funding bodyAustralian Brain Foundation
Project Team
SchemeResearch Grant
RoleLead
Funding Start2002
Funding Finish2002
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20011 grants / $7,250

Magnetic Resonance Imaging studies of microvascular flow and brain compliance in dementia and cognitive impairment$7,250

Funding body: John Hunter Hospital Charitable Trust Fund

Funding bodyJohn Hunter Hospital Charitable Trust Fund
Project Team
SchemeResearch Grant
RoleLead
Funding Start2001
Funding Finish2001
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20001 grants / $4,000

A Structure-function study of the neurotransmitter serotonin (type 3) for the development of psychotherapeutic drugs.$4,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamDr Kaneez Fatima-Shad, Conjoint Professor Richard Barry, Conjoint Associate Professor Peter Schofield
SchemeProject Grant
RoleInvestigator
Funding Start2000
Funding Finish2000
GNoG0178901
Type Of FundingInternal
CategoryINTE
UONY

19991 grants / $15,000

Knowledge of stroke and stroke symptoms in stroke patients and a 'stroke prone' population: a study of factors influencing time to presentation with acute stroke$15,000

Funding body: Hunter Medical Research Institute (HMRI)

Funding bodyHunter Medical Research Institute (HMRI)
Project Team
SchemeUnknown
RoleLead
Funding Start1999
Funding Finish1999
GNo
Type Of FundingExternal
CategoryEXTE
UONY
Edit

Research Supervision

Current Supervision

CommencedResearch Title / Program / Supervisor Type
2011Concussion in Professional Rugby League. What are the Potential Long- Term Consequences of Repetitive Concussive Blows
General Medicine, Faculty of Health and Medicine
Co-Supervisor
2011Quantitative Magnetic Resonance Imaging Biomarkers in Neurodegenerative Disorders and Ageing.
General Medicine, Faculty of Health and Medicine
Principal Supervisor

Past Supervision

YearResearch Title / Program / Supervisor Type
2014The Role of L-Arginine and Methylated-Arginines in Health and Disease
Public Health, Faculty of Health and Medicine
Co-Supervisor
2007Validation of Self-Report with Medical Records for Events of Traumatic Brain Injury in Males Passing Through the NSW Criminal Justice System
Psychiatry, Faculty of Health and Medicine
Principal Supervisor
Edit

News

PhD Opportunity - Biomarker for early Alzheimer's disease

PhD Opportunity - Biomarker for early Alzheimer's disease

February 3, 2015

A PhD opportunity exists for someone with biological and analytic skills who would be interested in taking advantage of collected data from an NHMRC funded study focussed on a novel potential biomarker for early Alzheimer's disease under the supervision of Conjoint Associate Professor Peter Schofield and Professor John Attia.

Conjoint Associate Professor Peter Schofield

Positions

Conjoint Associate Professor
Neuropsychiatry Service
School of Medicine and Public Health
Faculty of Health and Medicine

Conjoint Associate Professor
Neuropsychiatry Service
School of Psychology
Faculty of Science and Information Technology

Contact Details

Emailpeter.schofield@newcastle.edu.au
Phone(02) 4033 5739
Mobile0438649211
Fax(02) 4033 5606

Office

Room5031
BuildingLevel 5 McAuley Building
LocationCalvary MAter Newcastle Hospital Site

,
Edit